1036756-07-6 Usage
Uses
Given the provided materials, the specific applications of 6-Bromo-2-chloro-5-fluoro-quinazoline have not been extensively reported. However, based on the general properties of quinazoline compounds, potential uses can be inferred:
Used in Pharmaceutical Industry:
6-Bromo-2-chloro-5-fluoro-quinazoline is used as a potential active pharmaceutical ingredient for the development of new drugs. Its unique structural features and the biological activities associated with quinazoline compounds suggest that it may have therapeutic applications, possibly in the treatment of various diseases or conditions.
Used in Agrochemical Industry:
6-Bromo-2-chloro-5-fluoro-quinazoline is used as a potential lead compound in the development of agrochemicals. 6-BroMo-2-chloro-5-fluoro-quinazoline's structural characteristics and the known biological activities of quinazoline derivatives may offer advantages in the creation of new pesticides, herbicides, or other agricultural chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 1036756-07-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,6,7,5 and 6 respectively; the second part has 2 digits, 0 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1036756-07:
(9*1)+(8*0)+(7*3)+(6*6)+(5*7)+(4*5)+(3*6)+(2*0)+(1*7)=146
146 % 10 = 6
So 1036756-07-6 is a valid CAS Registry Number.
1036756-07-6Relevant articles and documents
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
-
, (2015/05/05)
Described herein are inhibitors of FGFR-4, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.
NEW CHEMICAL COMPOUNDS
-
Page/Page column 80, (2010/04/03)
The present invention encompasses compounds of general formula (1) while the groups R4 to R7 and the units W, L, Qa and QH are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use as medicaments having the above-mentioned properties.